Backpage: Nailing Down DTC Promotion - Pharmaceutical Executive

ADVERTISEMENT

Backpage: Nailing Down DTC Promotion
Before FDA and industry can find a solution to DTC promotion, they need to nail down the problem.


Pharmaceutical Executive


Questions Left Unanswered Despite FDA holding hearings, and PhRMA issuing guidelines to help diminish controversial promotional activity, it remains unclear what specific problem needs to be addressed in order to improve industry's use of direct-to-consumer marketing.

Lou Morris is president of Louis A. Morris & Associates. He can be reached at


ADVERTISEMENT

blog comments powered by Disqus
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma Careers
Source: Pharmaceutical Executive,
Click here